Evidence map›Paper›PMID 42281106›Full record

ArticleSensors (Basel, Switzerland)2026

ILA-CSMA: Hybrid Sensing and Adaptive Fair Backoff for Large-Scale LoRa Networks.

Wenjie Cheng, Haoyang Cui, Hengwen Yu

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wenjie ChengFaculty of Artificial Intelligence, Shanghai University of Electric Power, Shanghai 201306, China.
Haoyang CuiFaculty of Artificial Intelligence, Shanghai University of Electric Power, Shanghai 201306, China.
Hengwen YuFaculty of Artificial Intelligence, Shanghai University of Electric Power, Shanghai 201306, China.ORCID 0009-0005-2054-3795

Funding

Natural Science Foundation of Shanghai 23ZR1424400
6 · The paper itself

Abstract

Dense Long Range (LoRa) networks suffer from packet loss when many end devices contend for the same unlicensed channel. Channel activity detection (CAD) can miss weak or cross-spreading-factor (cross-SF) transmissions, while a uniform carrier sense multiple access with collision avoidance (CSMA/CA) backoff rule ignores the different time-on-air (ToA) costs of SF7-SF12 packets. To address these two coupled problems, this paper proposes an interference-limit-aware CSMA protocol (ILA-CSMA). ILA-CSMA first combines CAD with an instantaneous received signal strength indicator (RSSI) test derived from the residual interference tolerance of the selected spreading factor, and then scales the contention window according to normalized ToA. The protocol is implemented in the Framework for LoRa (FLoRa), an OMNeT++-based LoRa network simulator, and is evaluated for networks with 100-2000 nodes. Compared with Pure ALOHA, Slotted ALOHA, standard CSMA/CA, and two ablation variants, ILA-CSMA improves dense-network access by jointly reducing hidden collisions and airtime imbalance. In the 2000-node case, it increases the packet delivery ratio (PDR) by about 20 percentage points relative to standard CSMA/CA, keeps the Jain fairness index (JFI) above the 0.85 reference line, reduces the energy consumed per successful packet to 22% of the standard CSMA/CA value, and reduces conditional average packet delay from 18.5 s to 8.2 s. These results show that interference-aware sensing and ToA-aware backoff can improve large-scale LoRa access under the evaluated simulation conditions.

Indexed as

adaptive backoffcross-SF interferencefairnessLoRaLoRaWANmedium access controlRSSI sensingwireless sensor networks

Identifiers

PMID42281106
PMCPMC13259383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.